Karim Bennaceur

712 total citations
14 papers, 398 citations indexed

About

Karim Bennaceur is a scholar working on Immunology, Cardiology and Cardiovascular Medicine and Oncology. According to data from OpenAlex, Karim Bennaceur has authored 14 papers receiving a total of 398 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Immunology, 4 papers in Cardiology and Cardiovascular Medicine and 4 papers in Oncology. Recurrent topics in Karim Bennaceur's work include Neutrophil, Myeloperoxidase and Oxidative Mechanisms (4 papers), Telomeres, Telomerase, and Senescence (4 papers) and Atherosclerosis and Cardiovascular Diseases (4 papers). Karim Bennaceur is often cited by papers focused on Neutrophil, Myeloperoxidase and Oxidative Mechanisms (4 papers), Telomeres, Telomerase, and Senescence (4 papers) and Atherosclerosis and Cardiovascular Diseases (4 papers). Karim Bennaceur collaborates with scholars based in United Kingdom, United States and Germany. Karim Bennaceur's co-authors include Ioakim Spyridopoulos, Bernard Keavney, Rajiv Das, Mohaned Egred, Evgeniya V. Shmeleva, Azfar Zaman, Alan Bagnall, Gavin D. Richardson, Kamel Sanhadji and Jean‐Louis Touraine and has published in prestigious journals such as Journal of Clinical Investigation, European Heart Journal and Arteriosclerosis Thrombosis and Vascular Biology.

In The Last Decade

Karim Bennaceur

14 papers receiving 395 citations

Peers

Karim Bennaceur
Miranda Versloot Netherlands
Karim Bennaceur
Citations per year, relative to Karim Bennaceur Karim Bennaceur (= 1×) peers Miranda Versloot

Countries citing papers authored by Karim Bennaceur

Since Specialization
Citations

This map shows the geographic impact of Karim Bennaceur's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karim Bennaceur with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karim Bennaceur more than expected).

Fields of papers citing papers by Karim Bennaceur

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Karim Bennaceur. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karim Bennaceur. The network helps show where Karim Bennaceur may publish in the future.

Co-authorship network of co-authors of Karim Bennaceur

This figure shows the co-authorship network connecting the top 25 collaborators of Karim Bennaceur. A scholar is included among the top collaborators of Karim Bennaceur based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Karim Bennaceur. Karim Bennaceur is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Bawamia, Bilal, Karim Bennaceur, Konstantinos Stellos, et al.. (2023). Activation of telomerase by TA-65 enhances immunity and reduces inflammation post myocardial infarction. GeroScience. 45(4). 2689–2705. 16 indexed citations
2.
Redgrave, Rachael E., Esha Singh, Simon Tual‐Chalot, et al.. (2023). Exogenous Transforming Growth Factor-β1 and Its Helminth-Derived Mimic Attenuate the Heart's Inflammatory Response to Ischemic Injury and Reduce Mature Scar Size. American Journal Of Pathology. 194(4). 562–573. 6 indexed citations
3.
Mohammed, Ashfaq, Pedram Panahi, Karim Bennaceur, et al.. (2021). The Fractalkine Receptor CX3CR1 Links Lymphocyte Kinetics in CMV-Seropositive Patients and Acute Myocardial Infarction With Adverse Left Ventricular Remodeling. Frontiers in Immunology. 12. 605857–605857. 14 indexed citations
4.
Maier, Rebecca, Bilal Bawamia, Karim Bennaceur, et al.. (2020). Telomerase Activation to Reverse Immunosenescence in Elderly Patients With Acute Coronary Syndrome: Protocol for a Randomized Pilot Trial. JMIR Research Protocols. 9(9). e19456–e19456. 16 indexed citations
5.
Sopova, Kateryna, Karim Bennaceur, Seyed Mohammad Alavi, et al.. (2020). Interferon-gamma inducible protein IP-10 and left ventricular remodelling post-acute myocardial infarction: a longitudinal cardiovascular magnetic resonance imaging substudy of CAPRI clinical trial. European Heart Journal. 41(Supplement_2). 1 indexed citations
6.
Richardson, Gavin D., Andrew P. Sage, Karim Bennaceur, et al.. (2018). Telomerase Mediates Lymphocyte Proliferation but Not the Atherosclerosis-Suppressive Potential of Regulatory T-Cells. Arteriosclerosis Thrombosis and Vascular Biology. 38(6). 1283–1296. 26 indexed citations
7.
Drummond, Catherine J., Junfeng Liu, Xiaohong Lü, et al.. (2016). TP53 mutant MDM2-amplified cell lines selected for resistance to MDM2-p53 binding antagonists retain sensitivity to ionizing radiation. Oncotarget. 7(29). 46203–46218. 16 indexed citations
8.
Shmeleva, Evgeniya V., Karim Bennaceur, Rajiv Das, et al.. (2015). Differences in immune responses between CMV‐seronegative and ‐seropositive patients with myocardial ischemia and reperfusion. Immunity Inflammation and Disease. 3(2). 56–70. 7 indexed citations
9.
Das, Rajiv, Evgeniya V. Shmeleva, Alan Bagnall, et al.. (2015). T lymphocytes and fractalkine contribute to myocardial ischemia/reperfusion injury in patients. Journal of Clinical Investigation. 125(8). 3063–3076. 120 indexed citations
10.
Jackson, Arthur, Sophia Ward, Paula Bertram, et al.. (2014). Autoantibodies to CD59, CD55, CD46 or CD35 are not associated with atypical haemolytic uraemic syndrome (aHUS). Molecular Immunology. 63(2). 287–296. 5 indexed citations
11.
Bennaceur, Karim, Jedrzej Hoffmann, Bernard Keavney, et al.. (2014). Atorvastatin induces T cell proliferation by a telomerase reverse transcriptase (TERT) mediated mechanism. Atherosclerosis. 236(2). 312–320. 41 indexed citations
12.
Kavanagh, David, Isabel Y. Pappworth, Holly E. Anderson, et al.. (2012). Factor I Autoantibodies in Patients with Atypical Hemolytic Uremic Syndrome. Clinical Journal of the American Society of Nephrology. 7(3). 417–426. 49 indexed citations
13.
Watson, Anna, Junfeng Liu, Karim Bennaceur, et al.. (2011). MDM2-p53 protein–protein interaction inhibitors: A-ring substituted isoindolinones. Bioorganic & Medicinal Chemistry Letters. 21(19). 5916–5919. 37 indexed citations
14.
Bennaceur, Karim, et al.. (2008). Dendritic cells dysfunction in tumour environment. Cancer Letters. 272(2). 186–196. 44 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026